Mid- and post-ABVD gallium scanning predicts for recurrence in early-stage Hodgkin's disease

Although a positive mid- or postchemotherapy gallium scan was an adverse prognostic factor for OS, FFTF, and PFS, continued treatment with conventional-dose therapy may be adequate in selected patients with positive scans.